Stock SPARC SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Sun Pharma Advanced Research Company Limited

Equities

SPARC

INE232I01014

Delayed NSE India S.E.
Other stock markets
 11:53:14 2024-05-15 pm EDT 		5-day change 1st Jan Change
220 INR +1.20% Intraday chart for Sun Pharma Advanced Research Company Limited -1.32% -24.20%
Apr. 15 Transcript : Sun Pharma Advanced Research Company Limited - Special Call
Apr. 10 Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Sun Pharma Advanced Research Company Limited - Special Call
Sun Pharma Advanced Research Company Limited Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease
CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Transcript : Sun Pharma Advanced Research Company Limited - Special Call
Ocular Hypertension Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | Nicox, Qlaris Bio, TheratOcular Biotek Co., Ltd., Ocular Therapeutix, Whitecap Biosciences, and others.
AQ
Transcript : Sun Pharma Advanced Research Company Limited - Special Call
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Sun Pharma Advanced Research Company Limited Announces Retirement of Chitturi Trinadha Rao as Senior Vice President, Drug Discovery
CI
Sun Pharma Advanced Research : Update on Clinical Programs and R&D Pipeline
PU
Sun Pharma Advanced Research : SPARC enters into an exclusive worldwide license agreement for SCD-153 with JHU and IOCB
PU
Sun Pharma Advanced Research : SPARC Completes Enrolment in PROSEEK, A Global Phase 2 Study of Vodobatinib in Early Parkinson’s Disease
PU
Sun Pharma Advanced Research Company Ltd. Completes Enrolment in Proosek, A Global Phase 2 Study of Vodobatinib in Early Parkinson's Disease
CI
Sun Pharma Advanced Research : SPARC to Provide Update on Clinical Programs and R&D Pipeline
PU
Sun Pharma Advanced Research Company Limited Announces Incorporation of Wholly Owned Subsidiary Company
CI
Sun Pharma Advanced Research Company Limited Appoints Kajal Damania as Company Secretary
CI
Sun Pharma Advanced Research Company Limited Announces the Resignation of Mr. Dinesh Lahoti as Company Secretary and Compliance Officer
CI
Sun Pharma Advanced Research : AGM Speech 2022-23
PU
Sun Pharma Advanced Research Company Limited Announces Resignation of Dinesh Lahoti as Company Secretary and Compliance Officer, Effective September 11, 2023
CI
Sun Pharma Advanced Research Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Sun Pharma Advanced Research : FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SPARC Stock
  4. News Sun Pharma Advanced Research Company Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW